key: cord-0844388-ai6u5suo authors: Park, Ae Kyung; Rhee, Jee Eun; Kim, Il‐Hwan; Kim, Heui Man; Lee, Hyeokjin; Kim, Jeong‐Ah; Lee, Chae Young; Lee, Nam‐Joo; Woo, SangHee; Lee, Jaehee; No, Jin Sun; Rhie, Gi‐Eun; Wang, Seong Jin; Lee, Sang‐Eun; Park, Young Joon; Park, Gemma; Kim, Jung Yeon; Gwack, Jin; Yoo, Cheon‐Kwon; Kim, Eun‐Jin title: Genomic evidence of SARS‐CoV‐2 reinfection in the Republic of Korea date: 2021-12-09 journal: J Med Virol DOI: 10.1002/jmv.27499 sha: 21b9c4a71f96eb81fbfec123483d07756a1e3e48 doc_id: 844388 cord_uid: ai6u5suo As the coronavirus disease 2019 (COVID‐19) pandemic continues, reinfection is likely to become increasingly common. However, confirming COVID‐19 reinfection is difficult because it requires whole‐genome sequencing of both infections to identify the degrees of genetic differences. Since the first reported case of reinfection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in the Republic of Korea in April 2020, four additional cases were classified as suspected reinfection cases. We performed whole‐genome sequencing of viral RNA extracted from swabs obtained at the initial infection and reinfection stages of these four suspected cases. The interval between initial infection and reinfection of all four suspected cases was more than 3 months. All four patients were young (10–29 years), and they displayed mild symptoms or were asymptomatic during the initial infection and reinfection episodes. The analysis of genome sequences combined with the epidemiological results revealed that only two of the four cases were confirmed as reinfection, and both were reinfected with the Epsilon variant. Due to the prolonged COVID‐19 pandemic, the possibility of reinfections with SARS‐CoV‐2 variants is increasing, as reported in our study. Therefore, continuous monitoring of cases is necessary. Coronavirus disease 2019 is continuing to spread worldwide, with around 219 million confirmed cases and more than 4.5 million deaths across almost 200 countries to date. In the Republic of Korea, the number of daily confirmed cases has been increasing in the face of a fourth wave of the pandemic. As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an entirely new type of coronavirus, there are still many questions about immunity and the possibility of reinfections. It has been generally assumed that once infected, individuals mount an immune response that prevents the second infection in the same individual. 1 However, as the pandemic continues, cases of reinfection have been reported worldwide. 2, 3 In particular, the possibility of reinfection was elevated after the emergence of variants with immune evasion capabilities. 4, 5 In December 2020, herd immunity was attained in Manaus, Brazil, where more than 75% of the local population had been infected with however, there has been a recent surge in the number of COVID-19 cases, which may have been caused by the P.1 variant. 6 With the increasing number of suspected reinfection cases, the Cen- (Table 2 ). According to the previous report and guidance of reinfection based on the CDC and ECDC, true reinfection must fulfill certain criteria, including isolation of the complete genome of the virus (and not just genomic fragments) from the first and second confirmed specimens, detection of noncirculating variant in the first infection episode, epidemiologic data, such as the history of re-exposure to patients with COVID-19 in the second event and timing between episodes, with a longer time interval between the two events favoring the reinfection hypothesis. 18 Considering the criteria for true reinfection as stated above, among the four suspected reinfection cases, which were studied here, two of these were confirmed as reinfection based on epidemiological and virological data. Specifically, these two confirmed patients were reinfected with the Epsilon variant (B.1.429) which has been classified as a variant that was first identified in the United States. 19 As the Epsilon variant did not circulate during the initial infection period in Case 2 (March 2020) in the Republic of Korea, we can hypothesize that the patient was reinfected, even in the absence of a genomic sequence for the initial infection sample. The analysis of sequencing results of the viruses from the two samples (initial infection and reinfection samples) in Case 3 indicated that they were totally clustered differently; thus, this case was reinfected. In both of the confirmed reinfection cases, the patients had no symptoms during their reinfection; of note, Patient 4 was also asymptomatic during the initial infection. We assume that a second infection presents with milder symptoms or no symptoms at all. This is consistent with the previous reports that COVID-19 reinfections are milder than initial infections. 20 Therefore, these results emphasize the possibility of undetected SARS-CoV-2 reinfections and the need for surveillance of suspected SARS-CoV-2 reinfections. World Health Organization. COVID-19 natural immunity, Scientific brief COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing Genomic evidence for reinfection with SARS-CoV-2: a case study SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus Centers for Disease Control and Prevention Investigation criteria for suspected cases of SARS-CoV-2. Accessed European Centre for Disease Prevention and Control Reinfection with SARS-CoV-2: Considerations for public health response Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19 Identification of coronavirus isolated from a patient in Korea with COVID-19. Osong Public Health Res Perspect Genomic surveillance of SARS-CoV-2: distribution of clades in the Republic of Korea in 2020. Osong Public Health Res Perspect A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization FastTree 2--approximately maximumlikelihood trees for large alignments Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation Evidence of severe acute respiratory syndrome coronavirus 2 reinfection after recovery from mild coronavirus disease 2019 Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? Emergence of a novel SARS-CoV-2 variant in Southern California COVID-19 reinfections Genomic evidence of SARS-CoV-2 reinfection in the Republic of Korea The authors gratefully acknowledge researchers who have deposited and shared the genome data on GISAID's EpiCoV (https://www.gisaid.org/) database. This study was supported by a grant from the Korea Disease Control and Prevention Agency (grant number 4800-4837-301). The authors declare that there are no conflict of interests. The study was approved by the KDCA Institutional Review Board Sequences are available at GISAID: EPI_ISL_1675277, EPI_ISL_4570332, EPI_ISL_342, EPI_ISL_343, EPI_ISL_344.